Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorPARCESEPE, A.M.
dc.contributor.authorSTOCKTON, M.
dc.contributor.authorREMCH, M.
dc.contributor.authorWESTER, C.W.
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorBERNARD, Charlotte
dc.contributor.authorROSS, J.
dc.contributor.authorHAAS, A.D.
dc.contributor.authorAJEH, R.
dc.contributor.authorALTHOFF, K.N.
dc.contributor.authorENANE, L.
dc.contributor.authorPAPE, W.
dc.contributor.authorMINGA, A.
dc.contributor.authorKWOBAH, E.
dc.contributor.authorTLALI, M.
dc.contributor.authorTANUMA, J.
dc.contributor.authorNSONDE, D.
dc.contributor.authorFREEMAN, A.
dc.contributor.authorDUDA, S.N.
dc.contributor.authorNASH, D.
dc.contributor.authorLANCASTER, K.
dc.date.accessioned2024-10-30T14:41:16Z
dc.date.available2024-10-30T14:41:16Z
dc.date.issued2023-08-01
dc.identifier.issn1758-2652en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/203003
dc.description.abstractIntroduction: Common mental disorders (CMDs) are highly prevalent among people with HIV. Integrating mental healthcare into HIV care may improve mental health and HIV treatment outcomes. We describe the reported availability of screening andtreatment for depression, anxiety and post-traumatic stress disorder (PTSD) at global HIV treatment centres participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium in 2020 and changes in availability at sitesin low- or middle-income countries (LMICs) between 2016/2017 and 2020. Methods: In 2020, 238 sites contributing individual-level data to the IeDEA Consortium and in 2016/2017 a stratified random sample of IeDEA sites in LMICs were eligible to participate in site surveys on the availability of screening and treatment for CMDs. We assessed trends over time for 68 sites across 27 LMICs that participated in both surveys.Results: Among the 238 sites eligible to participate in the 2020 site survey, 227 (95%) participated, and mental health screening and treatment data were available for 223 (98%) sites across 41 countries. A total of 95 sites across 29 LMICs completed the 2016/2017 survey. In 2020, 68% of sites were in urban settings, and 77% were in LMICs. Overall, 50%, 14% and 12% of sites reported screening with a validated instrument for depression, anxiety and PTSD, respectively. Screening plus treatment in the form of counselling was available for depression, anxiety and PTSD at 46%, 13% and 11% of sites, respectively. Screening plus treatment in the form of medication was available for depression, anxiety and PTSD at 36%, 11% and 8% of sites, respectively. Among sites that participated in both surveys, screening for depression was more commonly available in 2020 than 2016/2017 (75% vs. 59%, respectively, p = 0.048). Conclusions: Reported availability of screening for depression increased among this group of IeDEA sites in LMICs between 2016/2017 and 2020. However, substantial gaps persist in the availability of mental healthcare at HIV treatment sites across global settings, particularly in resource-constrained settings. Implementation of sustainable strategies to integrate mental health services into HIV care is needed.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enHIV
dc.subject.enPTSD
dc.subject.enAnxiety
dc.subject.enDepression
dc.subject.enIntegration
dc.subject.enMental Health
dc.title.enAvailability of screening and treatment for common mental disorders in HIV clinic settings : data from the global International epidemiology Databases to evaluate AIDS (IeDEA) Consortium, 2016-2017 and 2020
dc.title.alternativeJ Int AIDS Socen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1002/jia2.26147en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologie/Psychiatrie et santé mentaleen_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologieen_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologie/Maladies infectieusesen_US
dc.identifier.pubmed37535703en_US
bordeaux.journalJournal of the International AIDS Societyen_US
bordeaux.pagee26147en_US
bordeaux.volume26en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue8en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamGHIGS_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDInstitut de Recherche pour le Développementen_US
bordeaux.import.sourcehal
hal.identifierhal-04533680
hal.version1
hal.popularnonen_US
hal.audienceNon spécifiéeen_US
hal.exportfalse
workflow.import.sourcehal
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.date=2023-08-01&rft.volume=26&rft.issue=8&rft.spage=e26147&rft.epage=e26147&rft.eissn=1758-2652&rft.issn=1758-2652&rft.au=PARCESEPE,%20A.M.&STOCKTON,%20M.&REMCH,%20M.&WESTER,%20C.W.&BERNARD,%20Charlotte&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée